IL159462A0 - Method and material for treating immune diseases - Google Patents

Method and material for treating immune diseases

Info

Publication number
IL159462A0
IL159462A0 IL15946202A IL15946202A IL159462A0 IL 159462 A0 IL159462 A0 IL 159462A0 IL 15946202 A IL15946202 A IL 15946202A IL 15946202 A IL15946202 A IL 15946202A IL 159462 A0 IL159462 A0 IL 159462A0
Authority
IL
Israel
Prior art keywords
immune diseases
treating immune
treating
diseases
immune
Prior art date
Application number
IL15946202A
Other languages
English (en)
Original Assignee
Glycogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycogenesys Inc filed Critical Glycogenesys Inc
Publication of IL159462A0 publication Critical patent/IL159462A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL15946202A 2001-06-22 2002-06-21 Method and material for treating immune diseases IL159462A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30036001P 2001-06-22 2001-06-22
US10/176,022 US20030004132A1 (en) 2001-06-22 2002-06-20 Method and material for treating immune diseases
PCT/US2002/019886 WO2003000195A2 (en) 2001-06-22 2002-06-21 Method and material for treating immune diseases

Publications (1)

Publication Number Publication Date
IL159462A0 true IL159462A0 (en) 2004-06-01

Family

ID=26871794

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15946202A IL159462A0 (en) 2001-06-22 2002-06-21 Method and material for treating immune diseases

Country Status (8)

Country Link
US (1) US20030004132A1 (https=)
EP (1) EP1408989A2 (https=)
JP (1) JP2004536825A (https=)
CN (1) CN100558368C (https=)
BR (1) BR0210547A (https=)
CA (1) CA2451885A1 (https=)
IL (1) IL159462A0 (https=)
WO (1) WO2003000195A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040223971A1 (en) * 2003-04-07 2004-11-11 Glycogenesys, Inc. Composition and uses of galectin antagonists
WO2004091634A1 (en) 2003-04-07 2004-10-28 Glycogenesys, Inc. Composition and uses of galectin antagonists
WO2005058352A2 (en) * 2003-12-17 2005-06-30 Entelos, Inc. Treatment of rheumatoid arthritis with galectin-3 antagonists
WO2005095463A1 (en) 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
ES2750126T3 (es) 2011-03-17 2020-03-25 Critical Care Diagnostics Inc Procedimientos de predicción del riesgo de un resultado clínico adverso
AU2012363033B2 (en) 2011-12-28 2016-06-02 Galectin Therapeutics, Inc. Composition of novel carbohydrate drug for treatment of human diseases
ES2848538T3 (es) * 2012-06-06 2021-08-10 Galectin Therapeutics Inc Composiciones de galacto-ramnogalacturonato para el tratamiento de enfermedades asociadas con elevada óxido nítrico sintasa inducible
DK2900061T3 (da) 2012-09-17 2020-03-02 Galectin Therapeutics Inc Fremgangsmåde til forstærkning af specifikke immunterapier ved cancerbehandling
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
US9907814B2 (en) 2012-12-20 2018-03-06 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
US12390486B2 (en) 2012-12-20 2025-08-19 Henry Ford Health System Method for treating diastolic heart failure by inhibiting galectin-3
US9339515B2 (en) 2013-02-20 2016-05-17 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis
CA3088736A1 (en) * 2018-01-21 2019-07-25 Rensselaer Polytechnic Institute Method of treating galectin-3 dependent disorders
US20210138080A1 (en) 2018-06-29 2021-05-13 Glykos Biomedical Oy Conjugates
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490991A (en) * 1986-07-03 1996-02-13 Advanced Magnetics, Inc. Directed delivery of radioprotectants using a receptor specific carrier
DE69118141T2 (de) * 1990-06-27 1996-09-19 Dainippon Ink & Chemicals Alkyliertes oligosaccharid und acetylderivate davon
US5498702A (en) * 1993-12-16 1996-03-12 California Natural Products Treated pectinic acid process and product
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
US5831052A (en) * 1997-05-07 1998-11-03 Incyte Pharmaceuticals, Inc. New human translocation associated protein
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US6500807B1 (en) * 1999-02-02 2002-12-31 Safescience, Inc. Modified pectin and nucleic acid composition
US6680306B2 (en) * 2001-06-21 2004-01-20 Glycogenesys, Inc. Method for enhancing the effectiveness of cancer therapies

Also Published As

Publication number Publication date
US20030004132A1 (en) 2003-01-02
BR0210547A (pt) 2004-05-25
JP2004536825A (ja) 2004-12-09
CA2451885A1 (en) 2003-01-03
CN1543352A (zh) 2004-11-03
WO2003000195A3 (en) 2003-03-20
CN100558368C (zh) 2009-11-11
WO2003000195A2 (en) 2003-01-03
EP1408989A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
IL157684A0 (en) Apparatus and method for photocosmetic and photodermatological treatment
GB0110288D0 (en) Composition and treatment method
EP1407114A4 (en) APPARATUS AND METHOD FOR INSTALLING ANCHOR BOLTS
GB0111413D0 (en) Apparatus and method
GB0119977D0 (en) Apparatus and method
GB0101259D0 (en) Apparatus and method
GB0129976D0 (en) Treatment method
IL159462A0 (en) Method and material for treating immune diseases
IL160561A0 (en) Method and composition for treating immune complex associated disorders
GB0105688D0 (en) Apparatus and method
GB0110732D0 (en) Apparatus and method
GB0109628D0 (en) Apparatus and method
EP1400212A4 (en) APPARATUS AND METHOD FOR TREATING JOINT DISEASES
EP1435772A4 (en) AQUACULTURE PROCESS AND DEVICE
GB0120147D0 (en) Treatment method
GB0101244D0 (en) Process and apparatus
EP1371744A4 (en) STEEL MATERIAL AND METHOD FOR MANUFACTURING THE SAME
GB0124303D0 (en) Material fabrication method and apparatus
SG102679A1 (en) Surface treatment method and material treated by the method
GB0101084D0 (en) Apparatus and method
GB0111411D0 (en) Apparatus and method
HK1064612A (en) Method and material for treating immune diseases
GB0114342D0 (en) Apparatus and method
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
GB0126253D0 (en) Treatment method